Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
91 hedge funds and large institutions have $406M invested in Calithera Biosciences, Inc in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 17 closing their positions.
35% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 26
6% more capital invested
Capital invested by funds: $382M → $406M (+$24M)
3% less funds holding
Funds holding: 94 → 91 (-3)
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
30% less call options, than puts
Call options by funds: $1.42M | Put options by funds: $2.04M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$7.27M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$4.9M |
| 3 |
Millennium Management
New York
|
+$3.98M |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.92M |
| 5 |
AC
Ascend Capital
Orinda,
California
|
+$3.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$10.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.15M |
| 3 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$7.31M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$3.67M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.57M |
CALA Hedge Fund Activity: Q3 2017 in Review
91 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q3 2017, worth a combined $406M — up 6.3% from $382M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of CALA and 14 opened new positions — a net loss of 3 holders — while 26 trimmed existing stakes and 35 added.
The largest buyer was AQR Capital Management, adding an estimated $7.27M. The largest seller was Adage Capital Partners, cutting an estimated $10.6M.
- 91 institutional investors held Calithera Biosciences, Inc (CALA) as of Q3 2017, down from 94 in Q2 2017.
- Funds reported $406M of Calithera Biosciences, Inc stock for Q3 2017, up 6.3% quarter-over-quarter.
- 14 funds opened new Calithera Biosciences, Inc positions in Q3 2017 and 17 closed out, a net change of -3 holders.
- The largest Calithera Biosciences, Inc buyer in Q3 2017 was AQR Capital Management, an estimated $7.27M added.
- The largest Calithera Biosciences, Inc seller in Q3 2017 was Adage Capital Partners, an estimated $10.6M sold.
Based on aggregated 13F filings for Q3 2017.